atenolol has been researched along with Blood Platelet Disorders in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Blood Platelet Disorders: Disorders caused by abnormalities in platelet count or function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zadionchenko, VS | 1 |
| Bagatyrova, KM | 1 |
| Adasheva, TV | 1 |
| Timofeeva, NIu | 1 |
| Zaporozhets, TP | 1 |
1 other study available for atenolol and Blood Platelet Disorders
| Article | Year |
|---|---|
[The therapeutic correction of disorders in thrombocyte-vascular hemostasis and of changes in the rheological properties of the blood in patients with arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Platelet Disorder | 1996 |